Cashu | News | SONN

HomeWatchlistNewsSignalsPicks

DJI

-0.59%

SPX

-0.05%

IXIC

+0.45%

FTSE

-0.15%

N225

+0.89%

AXJO

-0.24%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Sonnet BioTherapeutics Holdings News

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HBI, BFIN, PBBK, SONN on Behalf of Shareholders

Feature Image for interests on Banking & Financial Services, Consumer Cyclical, Financial Services, Stock from prnewswire.com

Why Is Sonnet BioTherapeutics Stock Trading Higher On Monday?

Feature Image for interests on Biotech, Briefs, Consumer Cyclical, News from benzinga.com

Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns

Feature Image for interests on Benzinga Neuro, Beta Bionics, Biotech, Cognition Therapeutics from benzinga.com

BURG SIMPSON ELDREDGE HERSH & JARDINE, P.C. AWARDED $55.5 MILLION VERDICT FOR CLIENT INJURED BY DEFECTIVE MULTICOOKER

Feature Image for interests on Consumer & Cosmetics, Consumer Cyclical, Household, Legal Issues from prnewswire.com

finance.yahoo.com

Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq

Feature Image for interests on Biotherapeutics, Company, Consumer Cyclical, Healthcare from finance.yahoo.com

finance.yahoo.com

Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India

Feature Image for interests on Alkem Laboratories, Autonomic Neuropathy, Cipn, Clinical Trials from finance.yahoo.com

finance.yahoo.com

Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive Programs

Feature Image for interests on Australia, Business Tax, Cash Proceeds, Consumer Cyclical from finance.yahoo.com

finance.yahoo.com

Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split

Feature Image for interests on Biotherapeutics, Common Stock, Company, Consumer Cyclical from finance.yahoo.com

finance.yahoo.com

Sonnet BioTherapeutics to Participate in the Virtual Investor Closing Bell Series

Feature Image for interests on Biotherapeutics, Chief Executive Officer, Consumer Cyclical, Pankaj Mohan from finance.yahoo.com

about 1 year ago

finance.yahoo.com

Sonnet BioTherapeutics (NASDAQ:SONN) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team

Feature Image for interests on Biotherapeutics, Chief Medical Officer, Consumer Cyclical, Investor Relations Firm from finance.yahoo.com

about 1 year ago

Stocks

Health Care

sonn

Sonnet BioTherapeutics Holdings

NASDAQ: SONN

+1.90 (+47.98%)

5.86

USD

At close at Sep 12, 20:43 UTC

Latest Cashu News

Sonnet BioTherapeutics Under Investigation Amid Merger Scrutiny by Halper Sadeh LLC

Sonnet BioTherapeutics Merger Faces Legal Scrutiny Amid Shareholder Concerns

Sonnet BioTherapeutics Merges with Rorschach I for Strategic Growth in Biotherapeutics